000 01296nam  2200301za 4500
0019.696297
003CaOODSP
00520231123084324
007cr |||||||||||
008150407|2012||||xxc|||||o    f|0| 0 eng d
020 |a978-1-100-20861-9
040 |aCaOODSP|beng
043 |an-cn---
0861 |aFR5-38/4-2012E-PDF
1101 |aCanada.|bForeign Affairs and International Trade Canada.
24510|aInvest in Canada - biopharmaceuticals, 2012 |h[electronic resource]
2463 |aBiopharmaceuticals - Canada's Competitive Advantages
260 |aOttawa - Ontario : |bForeign Affairs and International Trade |cFall 2012.
300 |a12p.|bcoloured figs.
5203 |aShowcases Canada as a location of choice for foreign direct investment.
590 |a13-32|b2013-08-09
69007|aInvestment policy|2gcpds
69007|aPharmaceutical industry|2gcpds
77508|tInvestir au Canada - produits biopharmaceutiques, 2012 |w(CaOODSP)9.640415
7760#|tInvest in Canada - biopharmaceuticals, 2012 |w(CaOODSP)9.652560
794 |tInvest in Canada : |w(CaOODSP)9.698723
795 |tInvest in Canada - biopharmaceuticals |w9.694494
85640|ahttp://publications.gc.ca|qPDF|s1.28 MB|uhttps://publications.gc.ca/collections/collection_2013/aecic-faitc/FR5-38-4-2012-eng.pdf